Zentalis Pharmaceuticals saw the highest growth of 0.74% in patent filings and no patents were granted in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.74% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Zentalis Pharmaceuticals’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Zentalis Pharmaceuticals has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 40% filings and 100% grants. The United States(US), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where Zentalis Pharmaceuticals is filings its patents. Among the top granted patent authorities, Zentalis Pharmaceuticals has 100% of its grants in United States(US).
Roche and Johnson & Johnson could be the strongest competitors for Zentalis Pharmaceuticals
Patents related to rare diseases lead Zentalis Pharmaceuticals's portfolio
Zentalis Pharmaceuticals has the highest number of patents in rare diseases. For rare diseases no patents were filed and 100% of patents were granted in Q2 2024.
Breast cancer related patents lead Zentalis Pharmaceuticals portfolio followed by ovarian cancer, and endometrial cancer
Zentalis Pharmaceuticals has highest number of patents in breast cancer followed by ovarian cancer, endometrial cancer, cervical cancer, and melanoma. For breast cancer, nearly 3% of patents were filed and 17% of patents were granted in Q2 2024.
For comprehensive analysis of Zentalis Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
